O
ONWARD Medical NV
XBRU:ONWD
ONWARD Medical NV
XBRU:ONWD
Price:
2.82
EUR
-2.25%
Market Closed
Market Cap:
€157.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
ONWARD Medical NV
XBRU:ONWD
|
NL |
|
Dexco SA
BOVESPA:DXCO3
|
BR |
|
LQR House Inc
NASDAQ:YHC
|
US |
|
Crops Corp
TSE:9428
|
JP |
|
S
|
Scor SE
OTC:SCRYY
|
FR |
|
S
|
Sonadezi Long Binh Share Holding Co
VN:SZB
|
VN |
Income Statement
Earnings Waterfall
ONWARD Medical NV
ONWARD Medical NV
Income Statement
ONWARD Medical NV
ONWARD Medical NV
Currency: EUR
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
6
|
0
|
2
|
0
|
1
|
0
|
2
|
0
|
2
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+386%
|
4
+240%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+314%
|
3
+219%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(29)
|
(34)
|
(32)
|
(36)
|
(36)
|
(36)
|
(35)
|
(37)
|
(44)
|
|
| Selling, General & Administrative |
(13)
|
(15)
|
(15)
|
(18)
|
(17)
|
(17)
|
(18)
|
(22)
|
(26)
|
|
| Research & Development |
(15)
|
(19)
|
(19)
|
(19)
|
(19)
|
(18)
|
(17)
|
(17)
|
(18)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
|
| Other Operating Expenses |
0
|
1
|
2
|
1
|
0
|
(0)
|
2
|
2
|
2
|
|
| Operating Income |
(29)
N/A
|
(34)
-19%
|
(32)
+5%
|
(36)
-12%
|
(35)
+1%
|
(36)
-2%
|
(35)
+3%
|
(36)
-4%
|
(41)
-13%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(6)
|
(4)
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
(2)
|
(0)
|
|
| Total Other Income |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
|
| Pre-Tax Income |
(34)
N/A
|
(37)
-9%
|
(34)
+10%
|
(37)
-9%
|
(36)
+1%
|
(36)
+0%
|
(36)
+1%
|
(38)
-7%
|
(41)
-9%
|
|
| Net Income | ||||||||||
| Tax Provision |
(0)
|
(0)
|
1
|
1
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(34)
|
(38)
|
(33)
|
(36)
|
(36)
|
(35)
|
(36)
|
(39)
|
(42)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(34)
N/A
|
(38)
-9%
|
(33)
+13%
|
(36)
-9%
|
(36)
-1%
|
(35)
+3%
|
(36)
-2%
|
(39)
-8%
|
(42)
-8%
|
|
| EPS (Diluted) |
-3.62
N/A
|
-1.24
+66%
|
-1.09
+12%
|
-1.2
-10%
|
-1.2
N/A
|
-1
+17%
|
-0.8
+20%
|
-0.87
-9%
|
-0.9
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
